Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. (Q51693683)

9 April 2018

title

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. (English)

1 reference

9 April 2018

1 reference

Patel JR

1

1 reference

9 April 2018

Földi J

2

1 reference

9 April 2018

Bateman H

3

1 reference

9 April 2018

Williams J

4

1 reference

9 April 2018

Didlick S

5

1 reference

9 April 2018

Stark R

6

1 reference

9 April 2018

publication date

1 March 2003

1 reference

9 April 2018

number of pages

17

1 reference

inferred from page(s)

published in

Veterinary Microbiology

1 reference

9 April 2018

volume

92

1 reference

9 April 2018

issue

1-2

1 reference

9 April 2018

page(s)

1-17

1 reference

9 April 2018

The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Response of ponies to adjuvanted EHV-1 whole virus vaccine and challenge with virus of the homologous strain

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

One way protection between equid herpesvirus 1 and 4 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Serological Detection of Equid Herpesvirus1 Infections of the Respiratory Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

Development and validation of a monoclonal antibody blocking ELISA for the detection of antibodies against both equine herpesvirus type 1 (EHV1) and equine herpesvirus type 4 (EHV4)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2802%2900358-9

7 January 2021

10.1016/S0378-1135(02)00358-9

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

12488066

1 reference

9 April 2018